Historical review from 2026-10-07. Current price and availability are unconfirmed; check the original marketplace.
isMalicious delivers $2,083/mo revenue with an exceptional 95% profit margin and a 1.47x annual profit multiple — both well above typical SaaS benchmarks. The 19-month operating history and TrustMRR platform verification (dataQualityScore: 100, no warnings) provide strong confidence in the disclosed financials. The security/threat intelligence niche serves a growing market segment. A buyer should confirm customer concentration, churn/retention metrics, and the operational scope of the multi-tool offering.
The core software—threat intelligence API aggregation, STIX/TAXII integration, and OpenCTI connectivity—can be built with AI-assisted coding, open-source libraries (STIX, OpenCTI SDKs), and managed security APIs in 10–14 weeks for $8K–$18K. However, the acquisition is compelling because it purchases $1,979/mo verified recurring profit with 95% margins, an established customer base, and operational knowledge of threat intelligence market dynamics and integration complexity. The business traction, profitability, and below-market valuation substantially outweigh software reproducibility; a solo founder rebuilding from scratch would require weeks of integration work, customer discovery, and churn risk that the existing business eliminates. **Buy** because proven cash flow and market validation are far more valuable than the commoditized software build.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
isMalicious is a suite of tools of cyberthreats intelligence, SIEM threatl intelligence API, STIX / TAXII, OpenCTI, MCP server.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.